Furthermore, in primary U-CLL samples, the cytotoxic effects of GPX4 inhibition were significantly enhanced by linoleic acid treatment, and the same effect was observed with ibrutinib (Fig. 5h, i). Here, GPX4 is linked to B-cell chronic lymphocytic leukemia.